HEIDELBERG UNIVERSITY

Luca Quagliata, PhD, discusses the journey of precision medicine, emphasizing the need for genomic profiling and decentralized clinical trials to enhance access and equity. He highlights the importance of collaboration with patients, pathologists, clinicians, payers, and pharma to realize the full potential of precision medicine globally.